FDA priority review seeks marstacimab label expansion to ≥6 years with inhibitors and ages 6–11 without inhibitors, addressing populations with limited efficacy from factor replacement and high unmet ...

Pfizer Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the company's supplemental Biologics License Application (sBLA) for HYMPAVZI® ...

MannKind Corporation drives 2026 momentum via Afrezza and FUROSCIX; label updates and execution risks define pharma ...

Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity February ...

The new Quality Management System Regulation (QMSR) that became effective on February 2, 2026, includes significant changes ...

The Prefilled Auto Injectors Market is poised for robust expansion driven by escalating incidence of chronic conditions, ...

EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European UnionARS Pharma’s partner, ...

EURneffy 1 mg will be the first and only needle-free adrenaline available to younger children in the European Union ...

Pharmapack 2026 celebrates record attendance and announces expansion to Asia PARIS, France, 2nd February, 2026 - Pharmapack 2026, Europe’s leading event for pharmaceutical packaging and drug delivery, ...

Five-cylinder engines are so rare because they didn't work well with carburetors when they were introduced, and they were ...

His containment strategy helped wipe out the disease in the 1970s, one of the world’s greatest public health triumphs. He ...

Together, Ram and Carrie strengthen Kaléo’s leadership team as the Company continues to support its autoinjector portfolio, advance development programs aligned with emergency preparedness, and ...